Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation

Qinwen Zheng,Yumeng Zhu,Aoxue Wang,Panpan Yang,Xin Wang,Wen Shuai,Liang Ouyang,Guan Wang

DOI: https://doi.org/10.15212/amm-2023-0028

2023-01-01

Acta Materia Medica

Abstract:Mitogen-activated protein kinases (MAPKs) are a group of serine-threonine protein kinases that can be activated by extracellular stimuli. MAPK14 (p38α) affects major disease processes, while inhibition of p38α has been shown to have potential therapeutic effects. Many inhibitors targeting p38α have entered clinical trials but have a long development cycle and severe side effects. We developed a multi-step receptor structure-based virtual screening method to screen potential bioactive molecules from SPECS and our MCDB libraries. Compound 10 was identified as a promising p38α inhibitor that may be used in the treatment of p38αMAPK pathway-related diseases, but corollary studies are warranted.